Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer

• Status: Unknown status
• Trial end date: 2007-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to visualize the tumor hypoxic tissue, the potential quantitative changes and the biological behavior of cervical carcinoma (primary and / or lymph nodes) before, during and after radiochemotherapy with the novel hypoxia PET tracer 18FAZA.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Vienna
• Treatments: Fluoroazomycin arabinoside

Criteria

Inclusion Criteria:

• First diagnosis of histologically proven cervical cancer FIGO stage IB2 to IVA.

• Treatment intention for the purpose of achieving cure

• Age < 80 years

• No previous standard or radical hysterectomy

Exclusion Criteria:

• Pregnancy, breast-feeding women, patients that are not able to lie motionless for one hour.Palliative treatment, recurrent disease, neoadjuvant chemotherapy, other pre-existing malignancies, age > 80 years,